TTOO

0.000912.50%
MA

Michael A. Pfaller

Member of Clinical Advisory Board

Dr. Michael A. Pfaller, also known as Mike, M.D., served as the Chief Medical Officer at T2 Biosystems, Inc. since April 2014 until July 18, 2017. Dr. Pfaller oversaw medical affairs including infectious disease and hemostasis advisory boards and clinical research and physician education programs associated with the anticipated launch of T2 Biosystems flagship diagnostic test, T2Candida, upon receipt of marketing authorization from the U.S. Food and Drug Administration (FDA). He has more than 35 years of clinical and medical research experience and is Professor Emeritus at the University of Iowa Hospitals. He is well-known for his role in recognizing and preparing seminal contributions in response to the threat to public health caused by nosocomial and community-acquired infections. He has also actively advised numerous pharmaceutical and biotechnology companies in drug discovery, development and marketing throughout his career. Certified by the American Board of Pathology in Clinical Pathology, he has made numerous research, teaching and clinical contributions in the areas of antifungal agents and resistance, epidemiology of bacterial and fungal infections and the role of the clinical microbiology laboratory in hospital infection control. Dr. Pfaller has been Member of Clinical Advisory Board at T2 Biosystems, Inc. since August 29, 2017. Dr. Pfaller earned his M.D. from the Washington University School of Medicine and his B.A. in chemistry from Linfield College.

Positions